Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Syncom Formulations India Ltd reported strong annual results for FY2025-26. Standalone revenue from operations grew 5.1% to Rs. 48,657 Lacs while consolidated revenue reached Rs. 48,917 Lacs. Standalone Profit After Tax surged 55.5% to Rs. 7,601 Lacs (vs Rs. 4,887 Lacs in FY25), and consolidated PAT rose 54.6% to Rs. 7,644 Lacs. EPS improved to Rs. 0.81 per share (restated) from Rs. 0.52 previously. The auditor issued an unmodified (clean) opinion with an Emphasis of Matter noting that EPS was restated for all prior periods after correcting the calculation methodology from Total Comprehensive Income to Profit After Tax per Ind AS 33. The company also recognized Rs. 87.81 Lacs incremental cost due to new labour codes effective November 2025.
Strong profitability growth with PAT up over 55% is positive for shareholders. The EPS restatement is a housekeeping correction and does not affect underlying business performance. Clean audit opinion with no qualifications supports financial reporting reliability.